Fuli Wang

Title: Fuli Wang: Innovator in Cancer Chemotherapy

Introduction

Fuli Wang is a notable inventor based in Xi'an, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on improving the efficacy and safety of chemotherapy for cancer patients.

Latest Patents

Fuli Wang holds a patent for "Methods of improving cancer chemotherapy." This patent provides methods and compositions aimed at prolonging survival and reducing or inhibiting tumor growth in cancer subjects undergoing chemotherapy. The invention involves the use of one or more chemotherapeutic agents, an inhibitor of soluble epoxide hydrolase (sEHi), and a non-steroidal anti-inflammatory drug (NSAID) that targets specific enzymes. The methods outlined in the patent are designed to decrease toxicity and adverse side effects associated with chemotherapy.

Career Highlights

Throughout his career, Fuli Wang has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His research has had a profound impact on the development of safer cancer treatment protocols.

Collaborations

Fuli Wang has collaborated with esteemed colleagues in his field, including Bruce D. Hammock and Sung Hee Hwang. Their combined expertise has contributed to advancements in cancer research and treatment methodologies.

Conclusion

Fuli Wang's innovative approaches to cancer chemotherapy exemplify the importance of research and development in medical science. His patented methods not only aim to enhance treatment outcomes but also prioritize patient safety.